Global cost effective analysis of apixaban versus warfarin for the prevention of stroke as a result of atrial fibrilation: a systematic review
cost-effective analysis
systematic review
This abstract was accepted for poster presentation at the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 23rd Annual International Meeting held in Baltimore, MD on May 21, 2018 The submitted abstract can be accessed using the link below.